HTG Molecular Diagnostics, Inc. (HTGMQ)
OTCMKTS: HTGMQ · Delayed Price · USD
0.0015
0.00 (0.00%)
Jul 19, 2024, 4:00 PM EDT - Market open
HTG Molecular Diagnostics Employees
As of December 31, 2022, HTG Molecular Diagnostics had 54 total employees, including 53 full-time and 1 part-time employees. The number of employees decreased by 34 or -38.64% compared to the previous year.
Employees
54
Change (1Y)
-34
Growth (1Y)
-38.64%
Revenue / Employee
$64,293
Profits / Employee
-$180,507
Market Cap
3.32K
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher | 122,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
Danaher | 63,000 |
HTGMQ News
- 1 year ago - HTG to Highlight the Advantages of its Drug Discovery Engine at the 2023 BIO International Convention - GlobeNewsWire
- 1 year ago - HTG Highlights the Advantages of Its Drug Discovery Engine - GlobeNewsWire
- 1 year ago - HTG Molecular Diagnostics Reports First Quarter 2023 Results and Provides Recent Business Highlights - GlobeNewsWire
- 1 year ago - HTG Technology Featured in Numerous Scientific Posters at the AACR Annual Meeting April 16-19 - GlobeNewsWire
- 1 year ago - HTG Provides a Year-End Update on its Drug Discovery Business and Attends LifeSci Partners 2023 Corporate Access Event - GlobeNewsWire
- 1 year ago - HTG Announces Certain Preliminary 2022 Unaudited Financial Results - GlobeNewsWire
- 1 year ago - HTG Molecular Diagnostics Provides Highlights of its Second Event in Drug Discovery KOL Webcast Series - GlobeNewsWire
- 1 year ago - HTG Molecular Diagnostics Announces Closing of a $10 Million Public Offering - GlobeNewsWire